2016
DOI: 10.1007/s10557-016-6669-y
|View full text |Cite
|
Sign up to set email alerts
|

GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…Pyruvate kinase, one of the major enzymes involved in glucose homeostasis, shows remarkable crosstalk with insulin levels in individuals with diabetes [31]. GSK-3, another key signaling molecule in the insulin pathway, modulates the process of glucose metabolism and is thus a particularly intriguing candidate target for diabetes treatment [32]. Consistent with previous studies that successfully confirmed the beneficial effects of natural products in diabetic conditions, the IOs ameliorated the metabolic disturbance of glycogen synthesis in diabetic mice.…”
Section: Discussionmentioning
confidence: 99%
“…Pyruvate kinase, one of the major enzymes involved in glucose homeostasis, shows remarkable crosstalk with insulin levels in individuals with diabetes [31]. GSK-3, another key signaling molecule in the insulin pathway, modulates the process of glucose metabolism and is thus a particularly intriguing candidate target for diabetes treatment [32]. Consistent with previous studies that successfully confirmed the beneficial effects of natural products in diabetic conditions, the IOs ameliorated the metabolic disturbance of glycogen synthesis in diabetic mice.…”
Section: Discussionmentioning
confidence: 99%
“…As previously described, through a signaling cascade, insulin plays an important role by activating pathways that lead to phosphorylation of GSK3β and inactivating this protein by an Akt‐dependent mechanism, thereby increasing GS activity and initiating glycogen synthesis (Perry et al, 2014). Thus, GSK3β activity has been described as a determinant in the genesis of complications associated with insulin resistance (Nabben & Neumann, 2016; Rao et al, 2007). In an elegant study, Rao et al (2007) observed that the use of L803‐mts (highly specific peptide inhibitor of GSK3) improved glycemic homeostasis and reduced hyperinsulinemia and hyperleptinemia in OB mice.…”
Section: Discussionmentioning
confidence: 99%
“…However, a large majority of these approaches rely on chronic interventions. Since the GSK-3β and mTORC signaling also regulate T cell proliferation and survival, the chronic interventions are limited and can produce side effects [25,26].…”
Section: Introductionmentioning
confidence: 99%